nach oben

Erschienen in:

01.02.2018 | Original Communication

Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study

verfasst von: Priscille Couture, Thibaud Chazal, Charlotte Rosso, Julien Haroche, Anne Léger, Baptiste Hervier, Sandrine Deltour, Zahir Amoura, Fleur Cohen Aubart

Erschienen in: Journal of Neurology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Takayasu arteritis (TA) is a giant cell arteritis usually affecting young women and characterized by inflammatory and ischemic signs of large vessel involvement, including extracranial cerebral arteries. The impact of stroke on TA prognosis has not been well evaluated.

Methods

We performed a retrospective multicenter review of patients with definite TA who experienced at least one stroke and compared the findings to 17 matched patients with TA diagnosis without neurological involvement.

Results

Seventeen patients (15 women, median age at stroke diagnosis 44 years) receiving a diagnosis of TA and stroke between 2002 and 2016 in our institution were included, from a cohort of 126 patients suffering from TA (13.5%). At diagnosis, patients from both groups had comparable cardiovascular risk factors. The first cerebrovascular event was ischemic stroke (n = 15) or transient ischemic attack (n = 2). In eight patients, stroke occurred after the TA diagnosis was made. In four patients, stroke occurred after carotid surgery. At the end of follow-up, 59% of patients had a neurological impairment, 35% had a recurrence of stroke, and 24% suffered from epilepsy.

Conclusions

Stroke is a major cause of disability in TA patients. Internal carotid surgery may be performed with caution because of the risk of stroke after the procedure.

Abisror N, Mekinian A, Lavigne C, Vandenhende MA, Soussan M, Fain O, Club Rhumatismes et I, Snfmi (2013) Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review. Autoimmun Rev 12:1143–1149CrossRefPubMed

Alibaz-Oner F, Direskeneli H (2015) Update on Takayasu’s arteritis. Presse Med 44:e259–e265CrossRefPubMed

Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134CrossRefPubMed

Arnaud L, Haroche J, Limal N, Toledano D, Gambotti L, Costedoat Chalumeau N, Le Thi Huong Boutin D, Cacoub P, Cluzel P, Koskas F, Kieffer E, Piette JC, Amoura Z (2010) Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Medicine 89:1–17CrossRefPubMed

Bejot Y, Couvreur G, Ricolfi F, Osseby GV, Cochet A, Giroud M (2011) Acute cerebrovascular manifestation of Takayasu arteritis. Am J Med 124:e5–e6CrossRefPubMed

Bond KM, Nasr D, Lehman V, Lanzino G, Cloft HJ, Brinjikji W (2017) Intracranial and extracranial neurovascular manifestations of Takayasu arteritis. AJNR Am J Neuroradiol 38:766–772CrossRefPubMed

Caballero PE (2011) Common carotid artery aneurysm revealing Takayasu’s arteritis. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 20:556–558CrossRef

Camara-Lemarroy CR, Lara-Campos JG, Perez-Contreras E, Rodriguez-Gutierrez R, Galarza-Delgado DA (2013) Takayasu’s arteritis and posterior reversible encephalopathy syndrome: a case-based review. Clin Rheumatol 32:409–415CrossRefPubMed

Comarmond C, Plaisier E, Dahan K, Mirault T, Emmerich J, Amoura Z, Cacoub P, Saadoun D (2012) Anti TNF-alpha in refractory Takayasu’s arteritis: cases series and review of the literature. Autoimmun Rev 11:678–684CrossRefPubMed

10.

de Paula LE, Alverne AR, Shinjo SK (2013) Clinical and vascular features of Takayasu arteritis at the time of ischemic stroke. Acta Reumatol Port 38:248–251PubMed

11.

Duarte MM, Geraldes R, Sousa R, Alarcao J, Costa J (2016) Stroke and transient ischemic attack in Takayasu’s arteritis: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 25:781–791CrossRef

12.

Fields CE, Bower TC, Cooper LT, Hoskin T, Noel AA, Panneton JM, Sullivan TM, Gloviczki P, Cherry KJ Jr (2006) Takayasu’s arteritis: operative results and influence of disease activity. J Vasc Surg 43:64–71CrossRefPubMed

13.

Ham SW, Kumar SR, Rowe VL, Weaver FA (2011) Disease progression after initial surgical intervention for Takayasu arteritis. J Vasc Surg 54:1345–1351CrossRefPubMed

14.

Hao R, Zhang J, Ma Z, Xiao M, Zhou L, Kang N, Liang X, Li F (2016) Takayasu’s arteritis presenting with common carotid artery dissection: a rare case report. Exp Ther Med 12:4061–4063CrossRefPubMedPubMedCentral

15.

Herlin B, Baud JM, Chadenat ML, Pico F (2015) Contrast-enhanced ultrasonography in Takayasu arteritis: watching and monitoring the arterial inflammation. BMJ Case Rep. https://doi.org/10.1136/bcr-2015-211094 PubMedPubMedCentral

16.

Hu J, Huang H, Zhang X, Li G, Liu Q, Wu M, Li G, Chen K, Shi S (2012) Stent placement for treatment of long segment (≥ 80 mm) carotid artery stenosis in patients with Takayasu disease. J Vasc Interv Radiol 23:1473–1477CrossRefPubMed

17.

Humayun MA, Masood A, Waseem T, Ahmad F, Raza T (2014) An unusual cause of stroke in a young female. Am J Emerg Med 32(685):e683–e685

18.

Hwang J, Kim SJ, Bang OY, Chung CS, Lee KH, Kim DK, Kim GM (2012) Ischemic stroke in Takayasu’s arteritis: lesion patterns and possible mechanisms. J Clin Neurol 8:109–115CrossRefPubMedPubMedCentral

19.

Jordan NP, Bezanahary H, D’Cruz DP (2015) Increased risk of vascular complications in Takayasu’s arteritis patients with positive lupus anticoagulant. Scand J Rheumatol 44:211–214CrossRefPubMed

20.

Kato Y, Dembo T, Takeda H, Fukuoka T, Nagoya H, Deguchi I, Maruyama H, Furuya D, Tanahashi N (2010) Stroke as a manifestation of Takayasu’s arteritis likely due to distal carotid stump embolism. Intern Med 49:695–699CrossRefPubMed

21.

Katoh N, Kubota M, Shimojima Y, Ishii W, Matsuda M, Akamatsu T, Ikeda S (2010) Takayasu’s arteritis in a patient with Crohn’s disease: an unexpected association during infliximab therapy. Intern Med 49:179–182CrossRefPubMed

22.

Kawano H, Toyoda K, Otsubo R, Hishikawa T, Minematsu K (2009) Tortuous carotid artery lumens in Takayasu’s arteritis. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 18:403–404CrossRef

23.

Keenan NG, Mason JC, Maceira A, Assomull R, O’Hanlon R, Chan C, Roughton M, Andrews J, Gatehouse PD, Firmin DN, Pennell DJ (2009) Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. Arthritis Rheum 60:3501–3509CrossRefPubMed

24.

Kim HJ, Suh DC, Kim JK, Kim SJ, Lee JH, Choi CG, Yoo B, Kwon SU, Kim JS (2005) Correlation of neurological manifestations of Takayasu’s arteritis with cerebral angiographic findings. Clin Imaging 29:79–85CrossRefPubMed

25.

Kumar VS, Dutt S, Bhat R (2014) Takayasu’s arteritis—stroke as an initial presentation. J Assoc Physicians India 62:623–627PubMed

26.

Kumral E, Evyapan D, Aksu K, Keser G, Kabasakal Y, Balkir K (2002) Microembolus detection in patients with Takayasu’s arteritis. Stroke 33:712–716CrossRefPubMed

27.

Lim AY, Lee GY, Jang SY, Gwag HB, Choi SH, Jeon ES, Cha HS, Sung K, Kim YW, Kim SM, Choe YH, Kim DK (2015) Gender differences in clinical and angiographic findings of patients with Takayasu arteritis. Clin Exp Rheumatol 33:S-132–S-137

28.

Liu Q, Dang A, Lv N, Wang X, Zheng D (2016) Anaemia and low body mass index are associated with increased cardiovascular disease in patients with Takayasu arteritis. Clin Exp Rheumatol 34:S16–S20PubMed

29.

Maeda Y, Taguchi H, Kudo T, Okano Y (2016) Takayasu arteritis and ischaemic stroke. QJM 109:45–46CrossRefPubMed

30.

Makin K, Isbel M, Nossent J (2017) Frequency, presentation, and outcome of Takayasu arteritis in Western Australia. Mod Rheumatol 27(6):1019–1023CrossRefPubMed

31.

Monti L, Servillo R, Grazzini I, Khader L, Acampa M, Cerase A (2017) Neuroimaging of Takayasu arteritis in a patient with ulcerative rectocolitis. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 26:e129–e132CrossRef

32.

Mustafa KN, Hadidy A, Sweiss NJ (2010) Clinical and radiological features of Takayasu’s arteritis patients in Jordan. Rheumatol Int 30:1449–1453CrossRefPubMed

33.

Numano F, Okawara M, Inomata H, Kobayashi Y (2000) Takayasu’s arteritis. Lancet 356:1023–1025CrossRefPubMed

34.

Osman M, Emery D, Yacyshyn E (2015) Tocilizumab for treating Takayasu’s arteritis and associated stroke: a case series and updated review of the literature. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 24:1291–1298CrossRef

35.

Park KC, Kim JH, Yoon SS, Heo SH (2008) Takayasu’s disease presenting with atherothrombotic ischaemic stroke. Neurol Sci 29:363–366CrossRefPubMed

36.

Park MC, Lee SW, Park YB, Chung NS, Lee SK (2005) Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34:284–292CrossRefPubMed

37.

Pereira VC, de Freitas CC, Luvizutto GJ, Sobreira ML, Peixoto DE, Magalhaes Ido N, Bazan R, Braga GP (2014) Stroke as the first clinical manifestation of Takayasu’s arteritis. Case Rep Neurol 6:271–274CrossRefPubMedPubMedCentral

38.

Pfefferkorn T, Bitterling H, Hufner K, Opherk C, Schewe S, Pfister HW, Straube A, Dichgans M (2008) Malignant hemispheric infarction in Takayasu arteritis. J Neurol 255:1425–1426CrossRefPubMed

39.

Ringleb PA, Strittmatter EI, Loewer M, Hartmann M, Fiebach JB, Lichy C, Weber R, Jacobi C, Amendt K, Schwaninger M (2005) Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology 44:1012–1015CrossRefPubMed

40.

Rustagi T, Majumder S (2011) Crohn’s–Takayasu’s arteritis overlap with hypercoagulability: an optimal milieu for ischemic stroke. J Dig Dis 12:142–146CrossRefPubMed

41.

Saadoun D, Lambert M, Mirault T, Resche-Rigon M, Koskas F, Cluzel P, Mignot C, Schoindre Y, Chiche L, Hatron PY, Emmerich J, Cacoub P (2012) Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation 125:813–819CrossRefPubMed

42.

Sharma BK, Jain S (1998) A possible role of sex in determining distribution of lesions in Takayasu Arteritis. Int J Cardiol 66(Suppl 1):S81–S84CrossRefPubMed

43.

Skeik N, Rumery KK, Udayakumar PD, Crandall BM, Warrington KJ, Sullivan TM (2013) Concurrent Takayasu arteritis with common variable immunodeficiency and moyamoya disease. Ann Vasc Surg 27(240):e213–e248

44.

Soto ME, Espinola N, Flores-Suarez LF, Reyes PA (2008) Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol 26:S9–S15PubMed

45.

Srinivas BC, Patra S, Reddy B, Nagesh CM, Manjunath CN (2013) Reocclusion and stroke due to immediate plaque protrusion following endovascular treatment of carotid artery successfully treated with intra-arterial urokinase and stent in stent in a patient with Takayasu arteritis with severe disease of all arch vessels. Cardiovasc Interv Ther 28:394–397CrossRefPubMed

46.

Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, Schieppati A, Baldissera E, Bertolini G, Itaka Study G (2005) Takayasu’s arteritis: a study of 104 Italian patients. Arthritis Rheum 53:100–107CrossRefPubMed

47.

Wheeler G, Kropf J, Jeanmonod R (2012) Vasculitis presenting with myocardial infarction, stroke, and aortitis in a middle-aged man. J Emerg Med 43:655–658CrossRefPubMed

48.

Yang L, Zhang H, Jiang X, Song L, Qin F, Zou Y, Wu H, Bian J, Zhou X, Hui R, Zheng D (2015) Clinical features and outcomes of Takayasu arteritis with neurological symptoms in China: a retrospective study. J Rheumatol 42:1846–1852CrossRefPubMed

49.

Zhu FP, Luo S, Wang ZJ, Jin ZY, Zhang LJ, Lu GM (2012) Takayasu arteritis: imaging spectrum at multidetector CT angiography. Br J Radiol 85:e1282–e1292CrossRefPubMedPubMedCentral

Titel: Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study
verfasst von: Priscille Couture
Thibaud Chazal
Charlotte Rosso
Julien Haroche
Anne Léger
Baptiste Hervier
Sandrine Deltour
Zahir Amoura
Fleur Cohen Aubart
Publikationsdatum: 01.02.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 4/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-018-8744-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Heterogeneous pattern of autonomic dysfunction in Parkinson’s disease

Early-onset subcortical ischemic vascular dementia in an adult with mtDNA mutation 3316G>A

Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in “de-novo” Parkinsonian subjects: a randomized controlled trial with 18-month follow-up

Advances in immunotherapeutic research for glioma therapy

Transthyretin familial amyloid polyneuropathy: an update